# [KMT2D]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |1   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|11.32        |
|BL    |Thomas cohort        |14.00        |
|BL    |Panea cohort         |15.80        |
|DLBCL |GAMBL genomes        |31.40        |
|DLBCL |Schmitz cohort       |34.50        |
|DLBCL |Reddy cohort         |22.30        |
|DLBCL |Chapuy cohort        |26.10        |
|FL    |GAMBL genomes        |67.67        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |No  |Yes                  | 0.689          |  13.459        |
|DLBCL |No  |Yes                  | 3.731          | 104.190        |
|FL    |No  |Yes                  |20.755          |1353.812        |


> [!NOTE]
> First described in BL in 2019 by [Grande BM](https://pubmed.ncbi.nlm.nih.gov/30617194). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)